Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,268
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,852
Class I recallsReasonable probability of serious health consequences
24,397
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,085 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-raw-mild-cheddar-cheese-due-potential-e-coli-o157h7Published October 15, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,397
Class I9,852
Class III2,897
Not Yet Classified2

Showing 201–220 of 21,432 recalls

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05

by Apollo Care, LLC

Reason
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

by Novartis Pharmaceuticals Corporation

Reason
Failed Dissolution Specifications
Published
August 19, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.

by Zydus Pharmaceuticals (USA) Inc

Reason
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
Published
August 12, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1

by Sunny Pharmtech Inc.

Reason
Presence of Particulate Matter; identified as stainless steel
Published
August 12, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Cyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8112-1

by Sunny Pharmtech Inc.

Reason
Presence of Particulate Matter; identified as stainless steel
Published
August 12, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., Atlanta, 1750 Corp Dr. Ste 725, Norcross, GA 30093 (844) 903-6418

by Central Admixture Pharmacy Services Inc

Reason
Incorrect Product Formulation
Published
August 12, 2026
Distribution
GA only

View recall →

FDA Recall Ongoing2026 recordClass II

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

by Aurobindo Pharma USA Inc

Reason
shortfill; reports of empty capsules.
Published
August 12, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass II

PT Organics Limited

Product
Pumpkin Tree Peter Rabbit Organics Banana & Strawberry fruit…
Reason
Possible foreign object (thin, soft plastic strands).
Published
August 12, 2026
Distribution
Distributed in AL, AZ, CA, CO, GA, IA, I…

View recall →

FDA Recall United States Ongoing2026 recordClass I

AKKARCO LLC

Product
Ashfiat Alharamain Energy Support 250ml/8fl. oz.
Reason
Undeclared tadalafil
Published
August 12, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass I

M.G. Foods, Inc.

Product
Spicy Breakfast Burrito sold under the following brand names…
Reason
Undeclared Soy. The firm received complaints of sausage in the burritos. Upon review the firm discovered the sausage contains soy which is not listed on the label.
Published
August 12, 2026
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Ongoing2026 recordClass III

Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-04.

by Ascend Laboratories, LLC

Reason
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Published
August 5, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68.

by Ascend Laboratories, LLC

Reason
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Published
August 5, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass III

Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7255-68.

by Ascend Laboratories, LLC

Reason
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Published
August 5, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.